Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 11.47B |
| Enterprise Value | 10.54B |
| P/E Ratio | 72.74 |
| PEG Ratio | 1.45 |
| Price/Sales Ratio | 5.85 |
| Price/Book Ratio | 2.11 |
| Enterprise/Revenue | 4.99 |
| Enterprise/EBITDA | 20.55 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.08 |
| Operating Margin | 0.13 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.03 |
Income Statement
| Revenue | 1.45B |
| Revenue/Share | 3.02 |
| Gross Profit | 1.02B |
| EBITDA | 335.87M |
| Net Income | 113.83M |
| Diluted EPS | 0.25 |
Balance Sheet
| Total Cash | 1.83B |
| Total Cash/Share | 4.01 |
| Total Debt | 43.68M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 1.93 |
| Book Value Per Share | 8.45 |
Price History
| 52-Week Change | -31.99 |
| 52-Week High | 32.99 |
| 52-Week Low | 16.24 |
| Moving Average 50 Days | 18.24 |
| Moving Average 200 Days | 22.08 |
Statistics
| Average Volume | 10.53M |
| Shares Outstanding | 455.1M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 16983:10000 |
| Last Split Date | January 24, 2007 |
AD
